Variant location is a novel risk factor for individuals with arrhythmogenic cardiomyopathy due to a desmoplakin ( DSP ) truncating variant
Authors:
Preprint
Abstract
Background: Truncating variants in desmoplakin ( DSP tv) are an important cause of arrhythmogenic cardiomyopathy (ACM), however the genetic architecture and genotype-specific risk factors are incompletely understood. We evaluated phenotype, risk factors for ventricular arrhythmias, and underlying genetics of DSP tv cardiomyopathy. Methods: Individuals with DSP tv and any cardiac phenotype, and their gene-positive family members were included from multiple international centers. Clinical data and family history information were collected. Event-free survival from ventricular arrhythmia was assessed. Variant location was compared between cases and controls, and literature review of reported DSP tv performed. Results: There were 98 probands and 72 family members (mean age at diagnosis 43 ± 18 years, 59% female) with a DSP tv, of which 146 were considered clinically affected. Ventricular arrhythmia (sudden cardiac arrest, sustained ventricular tachycardia, appropriate implantable cardioverter defibrillator therapy) occurred in 56 (33%) individuals. DSP tv location and proband status were independent risk factors for ventricular arrhythmia, while prior risk factors showed no association. Further, gene region was important with variants in cases (cohort n=98, Clinvar n=168) more likely to occur in the regions resulting in nonsense mediated decay of both major DSP isoforms, compared to n=124 gnomAD control variants (148 [83.6%] versus 29 [16.4%], pDSP tv, we demonstrate variant location is a novel risk factor for ventricular arrhythmia, can inform variant interpretation, and provide critical insights to allow precision-based clinical management.Keywords
All Related Versions
- Published version: Circulation: Genomic and Precision Medicine, 16 (1), 69.
This publication has 33 references indexed in Scilit:
- Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human studyEuropean Heart Journal, 2012
- Distinguishing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia–Associated Mutations From Background Genetic NoiseJACC, 2011
- Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasiaHeart, 2010
- Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaCirculation, 2010
- Lethal acantholytic epidermolysis bullosa due to a novel homozygous deletion inDSP: expanding the phenotype and implications for desmoplakin function in skin and heartBritish Journal of Dermatology, 2010
- Left-Dominant Arrhythmogenic CardiomyopathyJACC, 2008
- Comparison of Clinical Features of Arrhythmogenic Right Ventricular Cardiomyopathy in Men Versus WomenThe American Journal of Cardiology, 2008
- Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease ExpressionCirculation, 2007
- Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndromeJournal of Medical Genetics, 2006
- Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutationsEuropean Heart Journal, 2005